Inhalation Tuesday, February 20, 2018
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
Technical Articles
   
Item Details:
Publication Date: 12/2017
Pages: 5
Medium:
PDF Format
US:
$7.50
Recommended Item:
The influence of lactose fines in dry powder inhaler formulations

A study of the extent to which micronized lactose fines may improve dispersion behavior of DPI formulations

This study investigated the influence of lactose fines in ternary powder mixtures for inhalation by using different inhalers. Mixtures with and without commercially available lactose fines and the hydrophobic model drug budesonide were prepared. Aerodynamic behavior was tested with a Next Generation Impactor and three devices (Novolizer®, Cyclohaler® and Rack), chosen because of their different dispersion mechanisms. The addition of extrinsic lactose fines showed a significant improvement in the dispersion behavior for all tested devices.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.

Security:

Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway (Authorize.net) for processing.

Acrobat:

To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

HyperLink
      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy